Related Experiment Video
Updated: Jun 18, 2026
14:05
Behavioral Assessment of Hearing in 2 to 4 Year-old Children: A Two-interval, Observer-based Procedure Using Conditioned Play-based Responses
Published on: January 23, 2017
GIN (Gaps-In-Noise) performance in the pediatric population
Jennifer B Shinn1, Gail D Chermak, Frank E Musiek
1Division of Otolaryngology, Department of Surgery, University of Kentucky College of Medicine, Chandler Medical Center, B317 Kentucky Clinic, Lexington, KY, 40536-0284, USA.
Journal of the American Academy of Audiology
|November 26, 2009
Summary
The Gaps-In-Noise (GIN) test is feasible for assessing temporal resolution in children aged 7 and older. This auditory test shows no significant differences across age groups or between ears in pediatric populations.
Area of Science:
- Auditory Neuroscience
- Pediatric Audiology
- Neurodevelopmental Auditory Processing
Background:
- The Gaps-In-Noise (GIN) test is a novel diagnostic tool for temporal resolution deficits.
- Previous studies suggest the GIN test is sensitive for diagnosing central auditory processing disorder (CAPD) in adults.
Purpose of the Study:
- To evaluate the feasibility of the Gaps-In-Noise (GIN) test in pediatric populations.
- To determine if the GIN test can be reliably administered to children.
Main Methods:
- A prospective, pseudorandomized study involving 72 children aged 7–18 years.
- Participants were divided into six age groups.
- The GIN threshold was the dependent variable, analyzed using ANOVA.
Main Results:
- No statistically significant differences in GIN thresholds were observed across age groups (7–18 years).
- No significant differences were found between ears within age groups.
- Children as young as 7 years performed comparably to adults, indicating early and symmetrical development of temporal resolution.
Conclusions:
- The Gaps-In-Noise (GIN) test is a feasible measure for assessing temporal resolution in children.
- The findings support the GIN test's utility in both pediatric and adult populations.
- Temporal resolution, as measured by the GIN, develops early and symmetrically.
Related Concept Videos
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
01:29Drug Dosing: Infants and Children
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...